BIOMAT Database Logo BIOMAT Database Logo

[Iron deficiency anaemia due to a matriptase-2 mutation]. 2010

M L H Marloes Cuijpers, and Erwin T G Wiegerinck, and Rick Brouwer, and Theo J M de Witte, and Dorine W Swinkels
Universitair Medisch Centrum St. Radboud, Nijmegen, Afd. Hematologie, the Netherlands.

A 36-year old female patient who had had iron deficiency anaemia since her childhood showed no clear response to oral iron treatment. Elevated serum hepcidin levels were found after excluding other causes of iron deficiency. This is in contrast to what is expected in iron deficiency anaemia and indicates a primary defect in hepcidin regulation. Indeed, in the search for a defect in genes coding for hepcidin-regulating proteins the patient was found to be compound heterozygous for two different mutations in the TMPRSS6 gene. This leads to a dysfunctional matriptase-2 protein for which the gene codes. Consequently, liver cells cannot inhibit hepcidin production in the presence of low serum iron levels. High hepcidin levels result in less iron being absorbed from the bowel than is necessary for erythropoiesis. Therefore, patients with matriptase-2 deficiency respond poorly to oral iron treatment and have to be treated with intravenous iron.

UI MeSH Term Description Entries
D007501 Iron A metallic element with atomic symbol Fe, atomic number 26, and atomic weight 55.85. It is an essential constituent of HEMOGLOBINS; CYTOCHROMES; and IRON-BINDING PROTEINS. It plays a role in cellular redox reactions and in the transport of OXYGEN. Iron-56,Iron 56
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012697 Serine Endopeptidases Any member of the group of ENDOPEPTIDASES containing at the active site a serine residue involved in catalysis. Serine Endopeptidase,Endopeptidase, Serine,Endopeptidases, Serine
D017211 Treatment Failure A measure of the quality of health care by assessment of unsuccessful results of management and procedures used in combating disease, in individual cases or series. Failure, Treatment,Failures, Treatment,Treatment Failures
D018798 Anemia, Iron-Deficiency Anemia characterized by decreased or absent iron stores, low serum iron concentration, low transferrin saturation, and low hemoglobin concentration or hematocrit value. The erythrocytes are hypochromic and microcytic and the iron binding capacity is increased. Iron-Deficiency Anemia,Anemias, Iron-Deficiency,Iron-Deficiency Anemias,Anemia, Iron Deficiency,Anemias, Iron Deficiency,Iron Deficiency Anemia,Iron Deficiency Anemias

Related Publications

M L H Marloes Cuijpers, and Erwin T G Wiegerinck, and Rick Brouwer, and Theo J M de Witte, and Dorine W Swinkels
Is EPO therapy able to correct iron deficiency anaemia caused by matriptase-2 deficiency?
February 2011, British journal of haematology,
M L H Marloes Cuijpers, and Erwin T G Wiegerinck, and Rick Brouwer, and Theo J M de Witte, and Dorine W Swinkels
A novel mutation in the CUB sequence of matriptase-2 (TMPRSS6) is implicated in iron-resistant iron deficiency anaemia (IRIDA).
February 2013, British journal of haematology,
M L H Marloes Cuijpers, and Erwin T G Wiegerinck, and Rick Brouwer, and Theo J M de Witte, and Dorine W Swinkels
A novel mutation in the CUB sequence of matriptase-2 (TMPRSS6) is implicated in iron-resistant iron deficiency anaemia -- response to Jaspers et al.
February 2013, British journal of haematology,
M L H Marloes Cuijpers, and Erwin T G Wiegerinck, and Rick Brouwer, and Theo J M de Witte, and Dorine W Swinkels
PAPILLOEDEMA DUE TO IRON DEFICIENCY ANAEMIA.
June 1963, Acta haematologica,
M L H Marloes Cuijpers, and Erwin T G Wiegerinck, and Rick Brouwer, and Theo J M de Witte, and Dorine W Swinkels
Acquired iron-deficiency anaemia due to impaired iron transport.
January 1983, Lancet (London, England),
M L H Marloes Cuijpers, and Erwin T G Wiegerinck, and Rick Brouwer, and Theo J M de Witte, and Dorine W Swinkels
Matriptase-2 links erythropoietin to iron.
May 2016, Blood,
M L H Marloes Cuijpers, and Erwin T G Wiegerinck, and Rick Brouwer, and Theo J M de Witte, and Dorine W Swinkels
Iron Refractory Iron Deficiency Anaemia: A Rare Cause of Iron Deficiency Anaemia.
January 2018, Irish medical journal,
M L H Marloes Cuijpers, and Erwin T G Wiegerinck, and Rick Brouwer, and Theo J M de Witte, and Dorine W Swinkels
Conferon treatment in risk pregnancy due to iron deficiency anaemia.
January 1980, Therapia Hungarica (English edition),
M L H Marloes Cuijpers, and Erwin T G Wiegerinck, and Rick Brouwer, and Theo J M de Witte, and Dorine W Swinkels
Matriptase-2 deficiency protects from obesity by modulating iron homeostasis.
April 2018, Nature communications,
M L H Marloes Cuijpers, and Erwin T G Wiegerinck, and Rick Brouwer, and Theo J M de Witte, and Dorine W Swinkels
Hypochromic Anaemias Not Due to Iron Deficiency: Thalassaemia and Sideroblastic Anaemia.
April 1969, Journal of the Royal College of Physicians of London,
Copied contents to your clipboard!